Navigation Links
Bionovo Reports Third Quarter 2008 Financial Results
Date:11/3/2008

arly signs of clinical efficacy. The Phase 2 part of

the trial is now open for enrollment at 17 clinical sites in the

U.S., and is expected to enroll 80 patients in the trial. There are

currently over 160,000 women living with metastatic breast cancer in

the U.S.

-- The Company presented an analysis of the metabolism of one of the

active chemical ingredients of MF101, the Company's drug candidate

for the treatment of menopausal hot flashes. The presentation, to

the American Society for Pharmacology and Experimental Therapeutics,

Drug Metabolism and Disposition, adds to the growing body of data

supporting MF101's mechanism of action, safety and potential

potency, as well as furthering the intellectual property protection

for the Company.

-- Also on MF101, the Company released data from its previous Phase 2

study that showed MF101's superior efficacy with respect to "night

sweats" or "night awakenings due to hot flashes" -- a particularly

debilitating form of hot flash for which many women seek medical

treatment and improved quality of life. This adds to the increasing

evidence of the possible efficacy of MF101 and the market

opportunity awaiting MF101 if and when it is approved by the FDA and

put on the market.

-- The Company is currently in discussions with the FDA on the specific

requirements for progression to Phase 3 pivotal trials of MF101. The

Company expects to have resolution, and to be in a position to

continue the clinical development and trials for MF101, by the end

of the year.

-- The Company presented a report to the North American Menopause

Society (NAMS), showing laboratory results of superior efficacy for

VG101, the Company's drug candidate for menopausal vagin
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
2. Bionovo Announces Proposed Public Offering of Common Stock
3. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Bionovo Announces Third Quarter 2007 Financial Results
6. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
7. George Butler Joins Bionovos Board of Directors
8. Louis Drapeau Joins Bionovos Board of Directors
9. Bionovo Identifies and Describes ER-beta Selective Compounds for the Treatment of Vaginal Dryness
10. Bionovo to Present Recent Findings of BN107 and BN108, Its Anticancer Agents, at the American Association of Cancer Research
11. Bionovo Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 BioMedomics, Inc. ... ultra-sensitive POC diagnostic platforms and novel disease specific POC tests, ... of financing netting a total of $690,000. The investment is ... in the company. This group of private investors has significant ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... Md., May 5, 2011 GenVec, Inc. (NASDAQ: GNVCD) today ... letter from The NASDAQ Stock Market ("NASDAQ") advising that it ... GenVec had received a notice of deficiency on ... compliance with NASDAQ Marketplace Rules because the bid price of ...
... Reportlinker.com announces that a new market research report ... Tumor Markers - Global Pipeline Analysis, Competitive Landscape ... http://www.reportlinker.com/p0490349/Tumor-Markers---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html Tumor Markers - ... to 2017 Summary ...
... 4, 2011 Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: ... material, today announced that its chairman and CEO, Guy Cook, ... Equity Conference at the Hard Rock Hotel in Hollywood, Florida, ... At the time of the presentation, a live audio ...
Cached Biology Technology:GenVec Regains Compliance with NASDAQ Listing Requirements 2Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 13Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 14Bacterin International to Present at Noble Financial Capital Markets' Seventh Annual Equity Conference on May 16, 2011 2
(Date:7/10/2014)... are a big, bad sea scorpion. , One minute, ... any prey in sight. The next, thanks to a ... to trolling for weaker, soft-bodied animals you stumble upon ... giant pterygotid eurypterid, the largest arthropod that ever lived. ... journal Biology Letters , dramatically re-interprets the creature,s ...
(Date:7/10/2014)... The controversy centres around a family of enzymes known ... heme group in their active site. At the centre ... which becomes oxidised (ferryl) when a reacting heme is ... that has remained unanswered for decades is whether this ... hydroxyl group (OH). Resolving this fundamental question has implications ...
(Date:7/10/2014)... research from The University of Texas Health Science Center ... Real (IYG), a health education program designed to delay ... reduce dating violence behaviors among minority youth. , According ... percent of high school youth are victims of physical ... 20 percent are victims of emotional dating violence. Previous ...
Breaking Biology News(10 mins):Extinct sea scorpion gets a Yale eye exam, with surprising results 2Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3It's Your Game ... Keep It Real reduces dating violence among minority youth 2
... Brian Chen has been awarded a prestigious Sloan Research ... Formation, investigates a big subject: deciphering the assembly instructions ... neural circuits wire up with precision. One of the ... the correct synaptic contacts during its development when faced ...
... named Brontomerus mcintoshi , or "thunder-thighs" after its enormously powerful ... is described in a paper recently published in the journal ... the U.K. and the U.S. A member of the ... Brachiosaurus , Brontomerus may have used its powerful ...
... the crowd? Is that all I,ll ever be? ... Do you ... the Crowd" It may seem paradoxical, but being ... UCLA life scientists. Biologists Kimberly Pollard and Daniel ... alarm-call vocalizations in eight species of rodents that live in social ...
Cached Biology News:Prestigious Sloan Fellowship awarded 2New 'thunder-thighs' dinosaur discovered 2New 'thunder-thighs' dinosaur discovered 3Even in a crowd, you remain unique, UCLA life scientists report 2
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin...
... Analyst Software has been optimized for the ... allow the software to quickly and accurately ... well of an ELISA plate or each ... Software has been customized to incorporate standard ...
... An easy-to-use solution that enables fully automated ... 400 Hybridization Station has been designed to ... the throughput necessary to perform a wide ... performed in the range 485C; denaturations of ...
The Piezo Power MicroDissection (PPMD) system is designed for rapid isolation of single cells or small cell areas...
Biology Products: